Home > M&A deals 2011 > Myriad Genetics, Inc. acquires Rules-Based Medicine (RBM)
Add-on Acquistion · Life Science · June 2011

Myriad Genetics, Inc. acquires Rules-Based Medicine (RBM)

On June 1, 2011, Myriad Genetics, Inc. acquired Rules-Based Medicine (RBM), a life science company in Texas, United States, from Stephens Capital Partners.

Deal at a glance

AnnouncedJune 1, 2011 TypeAdd-on Acquistion TargetRules-Based Medicine (RBM) Buyer Myriad Genetics, Inc. Seller Stephens Capital Partners SectorLife Science LocationTexas, United States ValueMembers only

Target company

Rules-Based Medicine (RBM)
Texas, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Myriad Genetics, Inc.
Company · 10 deals on record
  • 1st transaction in life science
  • 1st transaction in United States
10deals, all time
5in this sector
2018latest

Seller

Stephens Capital Partners
Private equity firm · 71 deals on record
71investments
2in this sector
32exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Rules-Based Medicine (RBM)?Myriad Genetics, Inc. acquired Rules-Based Medicine (RBM) on June 1, 2011.

Who sold Rules-Based Medicine (RBM)?Stephens Capital Partners was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2011.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).